Role of Indian Medicinal Plants for Immunity Booster Against
SARS-CoV-2 Infection: An Updated Review

Kavita      Verma; Yoganchal      Mishra; Neha      Kapoor; Neelam      Yadav
Abstract

The coronavirus disease (COVID-19) came to be an epidemic that has occurred at the expense of the health of people. This disease reveals it can be lethal. Aged people and people with other medical occurrences may be more susceptible and become remarkably ill. The existing pandemic situation mandates scientific vigilance, hence we exploration to medicinal plants like Curcuma longa, Azadirachta indica, Ocimum sanctum, Tinospora cordifolia, Triphala, Phyllanthus emblica, Aloe barbadensis, Syzygium aromaticum, Cinnamomum verum, Allium cepa, Zingiber officinale, Piper nigrum, Allium sativum. The holistic Indian therapeutic system prescription is acknowledged as “Ayurveda”. Natural herbal remedies show more effectiveness which is moving towards the present day with the help of traditional medicine. The factual of the Immunity booster is to determine components of natural lineage have an antiviral outcome. This booster helps to prevent humans from infection caused by SARS-CoV-2. The molecular docking technique is used to disclose the interaction between molecules which is already researched, and the protein. In conclusion, the identified natural compounds from medicinal plants act as an herbal booster for increasing immunity in contradiction to SARS-CoV-2 contagion in patients.
Graphical Abstract

[1]
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med  2020; 382(8): 727-33.
 [http://dx.doi.org/10.1056/NEJMoa2001017]

[2]
Rao P, Shukla A, Parmar P, et al. Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CL pro of novel coronavirus SARS-CoV-2 identified using docking and molecular dynamics. J Biomol Struct Dyn  2022; 40(1): 348-60.
 [http://dx.doi.org/10.1080/07391102.2020.1813202] [PMID: 32875950]

[3]
Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn  2020; 39(9): 1-10.
 [http://dx.doi.org/10.1080/07391102.2020.1758788] [PMID: 32306836]

[4]
Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect  2020; 53(3): 365-7.
 [http://dx.doi.org/10.1016/j.jmii.2020.02.001] [PMID: 32035811]

[5]
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med  2020; 382(8): 727-33.
 [http://dx.doi.org/10.1056/NEJMoa2001017] [PMID: 31978945]

[6]
Elmezayen AD, Al-Obaidi A, Şahin AT, Yelekçi K. Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J Biomol Struct Dyn  2021; 39(8): 2980-92.
 [http://dx.doi.org/10.1080/07391102.2020.1758791] [PMID: 32306862]

[7]
Wu C, Liu Y, Yang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B  2020; 10(5): 766-88.
 [http://dx.doi.org/10.1016/j.apsb.2020.02.008] [PMID: 32292689]

[8]
Mackenzie JS, Smith DW. COVID-19: A novel zoonotic disease caused by a coronavirus from China: What we know and what we don’t. Microbiol Aust  2020; 41(1): 45.
 [http://dx.doi.org/10.1071/MA20013] [PMID: 32226946]

[9]
Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res  2020; 7(1): 11.
 [http://dx.doi.org/10.1186/s40779-020-00240-0] [PMID: 31928528]

[10]
Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J Biomol Struct Dyn  2021; 39(7): 2617-27.
 [http://dx.doi.org/10.1080/07391102.2020.1751300] [PMID: 32238078]

[11]
Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One  2020; 15(3): e0230548.
 [http://dx.doi.org/10.1371/journal.pone.0230548] [PMID: 32191764]

[12]
Chan JFW, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect  2020; 9(1): 221-36.
 [http://dx.doi.org/10.1080/22221751.2020.1719902] [PMID: 31987001]

[13]
Hasan A, Paray BA, Hussain A, et al. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn  2021; 39(8): 3025-33.
 [http://dx.doi.org/10.1080/07391102.2020.1754293] [PMID: 32274964]

[14]
Park JY, Ko JA, Kim DW, et al. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem  2016; 31(1): 23-30.
 [http://dx.doi.org/10.3109/14756366.2014.1003215] [PMID: 25683083]

[15]
Park JY, Kim JH, Kwon JM, et al. Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorg Med Chem  2013; 21(13): 3730-7.
 [http://dx.doi.org/10.1016/j.bmc.2013.04.026] [PMID: 23647823]

[16]
Park JY, Jae Jeong H, Hoon Kim J, et al. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol Pharm Bull  2012; 35(11): 2036-42.
 [http://dx.doi.org/10.1248/bpb.b12-00623] [PMID: 22971649]

[17]
Ryu YB, Jeong HJ, Kim JH, et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg Med Chem  2010; 18(22): 7940-7.
 [http://dx.doi.org/10.1016/j.bmc.2010.09.035] [PMID: 20934345]

[18]
Lin CW, Tsai FJ, Tsai CH, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res  2005; 68(1): 36-42.
 [http://dx.doi.org/10.1016/j.antiviral.2005.07.002] [PMID: 16115693]

[19]
Li S, Chen C, Zhang H, et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res  2005; 67(1): 18-23.
 [http://dx.doi.org/10.1016/j.antiviral.2005.02.007] [PMID: 15885816]

[20]
Jamshidi N, Cohen MM. The clinical efficacy and safety of Tulsi in humans: A systematic review of the literature. Evid Based Complement Alternat Med  2017; 2017: 1-13.
 [http://dx.doi.org/10.1155/2017/9217567] [PMID: 28400848]

[21]
Kapoor LD. Butea monospermaIn handbook of Ayurvedic medicinal plants.  CRC Press: Boca Raton 1990; p. 86.

[22]
Sharma P, Parmar J, Sharma P, Verma P, Goyal PK. Radiation-induced testicular injury and its amelioration by tinosporacordifolia (an Indian medicinal plant) extract. Evid Based Complement Alternat Med  2011; 2011: 1-9.
 [http://dx.doi.org/10.1155/2011/643847] [PMID: 21350610]

[23]
Ven MK, Ranjekar P, Ramassamy C, Deshpande M. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: Ashwagandha. Cent Nerv Syst Agents Med Chem  2010; 10(3): 238-46.

[24]
Vyas VK, Pratik B, Radheshyam P. A comprehensive review on Withania somnifera Dunal. J Nat Rem  2011; 11(1): 1-3.

[25]
Du HZ, Hou XY, Miao YH, Huang BS, Liu DH. Traditional Chinese Medicine: An effective treatment for 2019 novel coronavirus pneumonia (NCP). Chin J Nat Med  2020; 18(3): 206-10.
 [http://dx.doi.org/10.1016/S1875-5364(20)30022-4] [PMID: 32245590]

[26]
Xu Z, Peng C, Shi Y, et al. Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. BioRxiv 2019.

[27]
Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res  2020; 7(1): 4.
 [http://dx.doi.org/10.1186/s40779-020-0233-6] [PMID: 32029004]

[28]
Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe  2020; 27(3): 325-8.
 [http://dx.doi.org/10.1016/j.chom.2020.02.001] [PMID: 32035028]

[29]
Fehr AR, Perlman S. Coronaviruses: An overview of their replication and pathogenesis. Methods Mol Biol  2015; 1282: 1-23.
 [http://dx.doi.org/10.1007/978-1-4939-2438-7_1] [PMID: 25720466]

[30]
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet  2020; 395(10224): 565-74.
 [http://dx.doi.org/10.1016/S0140-6736(20)30251-8] [PMID: 32007145]

[31]
Lau YL, Peiris JSM. Pathogenesis of severe acute respiratory syndrome. Curr Opin Immunol  2005; 17(4): 404-10.
 [http://dx.doi.org/10.1016/j.coi.2005.05.009] [PMID: 15950449]

[32]
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med  2020; 46(4): 586-90.
 [http://dx.doi.org/10.1007/s00134-020-05985-9] [PMID: 32125455]

[33]
Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY. Coronaviruses — drug discovery and therapeutic options. Nat Rev Drug Discov  2016; 15(5): 327-47.
 [http://dx.doi.org/10.1038/nrd.2015.37] [PMID: 26868298]

[34]
Xu J, Zhao S, Teng T, et al. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses  2020; 12(2): 244.
 [http://dx.doi.org/10.3390/v12020244] [PMID: 32098422]

[35]
V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat Rev Microbiol  2021; 19(3): 155-70.
 [http://dx.doi.org/10.1038/s41579-020-00468-6] [PMID: 33116300]

[36]
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell  2020; 181(2): 271-80.

[37]
Perlman S, Netland J. Coronaviruses post-SARS: Update on replication and pathogenesis. Nat Rev Microbiol  2009; 7(6): 439-50.
 [http://dx.doi.org/10.1038/nrmicro2147] [PMID: 19430490]

[38]
Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA  2020; 117(21): 11727-34.
 [http://dx.doi.org/10.1073/pnas.2003138117] [PMID: 32376634]

[39]
Masters PS. The molecular biology of coronaviruses. Adv Virus Res  2006; 66: 193-292.
 [http://dx.doi.org/10.1016/S0065-3527(06)66005-3] [PMID: 16877062]

[40]
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature  2003; 426(6965): 450-4.
 [http://dx.doi.org/10.1038/nature02145] [PMID: 14647384]

[41]
Yamauchi Y, Helenius A. Virus entry at a glance. J Cell Sci  2013; 126(Pt 6): 1289-95.
 [PMID: 23641066]

[42]
Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses  2020; 12(2): 135.
 [http://dx.doi.org/10.3390/v12020135] [PMID: 31991541]

[43]
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci  2020; 63(3): 457-60.
 [http://dx.doi.org/10.1007/s11427-020-1637-5] [PMID: 32009228]

[44]
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. J Adv Res  2020; 24: 91-8.
 [http://dx.doi.org/10.1016/j.jare.2020.03.005] [PMID: 32257431]

[45]
Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr  2020; 87(4): 281-6.
 [http://dx.doi.org/10.1007/s12098-020-03263-6] [PMID: 32166607]

[46]
Sarfraz I, Rasul A, Hussain G, Adem S, Ali M. Natural Immune boosters as first-line armours to combat viral infection-COVID19: Myth or Science? Preprints  2020; 2020030427.
 [http://dx.doi.org/10.20944/preprints202003.0427.v1]

[47]
Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr  2020; 14(4): 367-82.
 [http://dx.doi.org/10.1016/j.dsx.2020.04.015] [PMID: 32334392]

[48]
Martineau AR, Jolliffe DA, Greenberg L, et al. Vitamin D supplementation to prevent acute respiratory infections: Individual participant data meta-analysis. Health Technol Assess  2019; 23(2): 1-44.
 [http://dx.doi.org/10.3310/hta23020] [PMID: 30675873]

[49]
Petric D. Immune system and COVID-19. Academia  2020; 2020: 1-5.

[50]
Gunville CM, Mourani PA, Ginde A. The role of vitamin D in prevention and treatment of infection. Inflamm Allergy Drug Targets  2013; 12(4): 239-45.
 [http://dx.doi.org/10.2174/18715281113129990046]

[51]
Lytle CD, Sagripanti JL. Predicted inactivation of viruses of relevance to biodefense by solar radiation. J Virol  2005; 79(22): 14244-52.
 [http://dx.doi.org/10.1128/JVI.79.22.14244-14252.2005] [PMID: 16254359]

[52]
Martin SA, Pence BD, Woods JA. Exercise and respiratory tract viral infections. Exerc Sport Sci Rev  2009; 37(4): 157-64.
 [http://dx.doi.org/10.1097/JES.0b013e3181b7b57b] [PMID: 19955864]

[53]
Nieman DC, Wentz LM. The compelling link between physical activity and the body’s defense system. J Sport Health Sci  2019; 8(3): 201-17.
 [http://dx.doi.org/10.1016/j.jshs.2018.09.009] [PMID: 31193280]

[54]
Ding S, Jiang H, Fang J. Regulation of immune function by polyphenols. J Immunol Res  2018; 2018: 1-8.
 [http://dx.doi.org/10.1155/2018/1264074] [PMID: 29850614]

[55]
Ma Y, Kosińska-Cagnazzo A, Kerr WL, Amarowicz R, Swanson RB, Pegg RB. Separation and characterization of soluble esterified and glycoside-bound phenolic compounds in dry-blanched peanut skins by liquid chromatography-electrospray ionization mass spectrometry. J Agric Food Chem  2014; 62(47): 11488-504.
 [http://dx.doi.org/10.1021/jf503836n] [PMID: 25354220]

[56]
Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab  2007; 51(4): 301-23.
 [http://dx.doi.org/10.1159/000107673] [PMID: 17726308]

[57]
Patel N, Penkert RR, Jones BG, et al. Baseline serum vitamin A and D levels determine benefit of oral vitamin A&D supplements to humoral immune responses following pediatric influenza vaccination. Viruses  2019; 11(10): 907.
 [http://dx.doi.org/10.3390/v11100907] [PMID: 31575021]

[58]
Ivory K, Prieto E, Spinks C, et al. Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults. Clin Nutr  2017; 36(2): 407-15.
 [http://dx.doi.org/10.1016/j.clnu.2015.12.003] [PMID: 26803169]

[59]
Kang EJ, Kim SY, Hwang IH, Ji YJ. The effect of probiotics on prevention of common cold: A meta-analysis of randomized controlled trial studies. Korean J Fam Med  2013; 34(1): 2-10.
 [http://dx.doi.org/10.4082/kjfm.2013.34.1.2] [PMID: 23372900]

[60]
Mousa HAL. Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies. J Evid Based Complementary Altern Med  2017; 22(1): 166-74.
 [http://dx.doi.org/10.1177/2156587216641831] [PMID: 27055821]

[61]
Huang Z, Liu Y, Qi G, Brand D, Zheng S. Role of vitamin A in the immune system. J Clin Med  2018; 7(9): 258.
 [http://dx.doi.org/10.3390/jcm7090258] [PMID: 30200565]

[62]
Siddiqui FQ, Ahmad MM, Kakar F, Akhtar S, Dil AS. twitter sharing button linkedin sharing button facebook sharing button whatsapp sharing button email sharing button print sharing button The role of vitamin A in enhancing humoral immunity produced by antirabies vaccine. East Mediterr Health J  2001; 7(4-5): 799-804.
 [http://dx.doi.org/10.26719/2001.7.4-5.799] [PMID: 15332782]

[63]
Anywar G, Kakudidi E, Byamukama R, Mukonzo J, Schubert A, Oryem-Origa H. Indigenous traditional knowledge of medicinal plants used by herbalists in treating opportunistic infections among people living with HIV/AIDS in Uganda. J Ethnopharmacol  2020; 246: 112205.
 [http://dx.doi.org/10.1016/j.jep.2019.112205] [PMID: 31476442]

[64]
Chauhan RS. Efficacy of herbal immuplus in enhancing humoral and cell mediated immunity in dogs. Livest Int  2001; 5: 12-8.

[65]
Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y. Vitamin D and autoimmunity. Scand J Rheumatol  2016; 45(6): 439-47.
 [http://dx.doi.org/10.3109/03009742.2016.1151072] [PMID: 27191042]

[66]
Lindenmayer GW, Stoltzfus RJ, Prendergast AJ. Interactions between zinc deficiency and environmental enteropathy in developing countries. Adv Nutr  2014; 5(1): 1-6.
 [http://dx.doi.org/10.3945/an.113.004838] [PMID: 24425714]

[67]
Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The role of zinc in antiviral immunity. Adv Nutr  2019; 10(4): 696-710.
 [http://dx.doi.org/10.1093/advances/nmz013] [PMID: 31305906]

[68]
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov  2020; 19(3): 149-50.
 [http://dx.doi.org/10.1038/d41573-020-00016-0]

[69]
Rupp JC, Locatelli M, Grieser A, et al. Host Cell Copper Transporters CTR1 and ATP7A are important for Influenza A virus replication. Virol J  2017; 14(1): 11.
 [http://dx.doi.org/10.1186/s12985-016-0671-7] [PMID: 28115001]

[70]
Miyamoto D, Kusagaya Y, Endo N, et al. Thujaplicin–copper chelates inhibit replication of human influenza viruses. Antiviral Res  1998; 39(2): 89-100.
 [http://dx.doi.org/10.1016/S0166-3542(98)00034-5] [PMID: 9806486]

[71]
Rayman MP. Selenium and human health. Lancet  2012; 379(9822): 1256-68.
 [http://dx.doi.org/10.1016/S0140-6736(11)61452-9] [PMID: 22381456]

[72]
Prasad S, Aggarwal BB. Herbal Medicine: Biomolecular and Clinical AspectsTurmeric, the golden spice.  (2nd ed...),  2011.
 [http://dx.doi.org/10.1201/b10787-14]

[73]
Ammon H, Wahl M. Pharmacology of Curcuma longa. Planta Med  1991; 57(1): 1-7.
 [http://dx.doi.org/10.1055/s-2006-960004] [PMID: 2062949]

[74]
Apisariyakul A, Vanittanakom N, Buddhasukh D. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol  1995; 49(3): 163-9.
 [http://dx.doi.org/10.1016/0378-8741(95)01320-2] [PMID: 8824742]

[75]
Araújo CAC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz  2001; 96(5): 723-8.
 [http://dx.doi.org/10.1590/S0074-02762001000500026] [PMID: 11500779]

[76]
Gupta H, Gupta M, Bhargava S. Potential use of turmeric in COVID-19. Clin Exp Dermatol  2020; 45(7): 902-3.
 [http://dx.doi.org/10.1111/ced.14357] [PMID: 32608046]

[77]
Thota SM, Balan V, Sivaramakrishnan V. Natural products as home-based prophylactic and symptom management agents in the setting of COVID -19. Phytother Res  2020; 34(12): 3148-67.
 [http://dx.doi.org/10.1002/ptr.6794] [PMID: 32881214]

[78]
Grzanna R, Lindmark L, Frondoza CG. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food  2005; 8(2): 125-32.
 [http://dx.doi.org/10.1089/jmf.2005.8.125] [PMID: 16117603]

[79]
Bhat J, Damle A, Vaishnav PP, Albers R, Joshi M, Banerjee G. In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs. Phytother Res  2010; 24(1): 129-35.
 [http://dx.doi.org/10.1002/ptr.2889] [PMID: 19504465]

[80]
Singh NA, Kumar P, Jyoti , Kumar N. Spices and herbs: Potential antiviral preventives and immunity boosters during COVID ‐19. Phytother Res  2021; 35(5): 2745-57.
 [http://dx.doi.org/10.1002/ptr.7019] [PMID: 33511704]

[81]
Malabadi RB, Chalannavar RK, Supriya S, Nityasree BR, Sowmyashree K, Meti NT. Role of botanical drugs in controlling dengue virus disease. Inter J Res Sci Innov  2018; 5(7): 134-59.

[82]
Bast F, Rani P, Meena D. Chloroplast DNA phylogeography of holy basil (Ocimum tenuiflorum) in Indian subcontinent. SciWorldJ  2014; 2014: 1-6.
 [http://dx.doi.org/10.1155/2014/847482] [PMID: 24523650]

[83]
Tang LIC, Ling APK, Koh RY, Chye SM, Voon KGL. Screening of anti-dengue activity in methanolic extracts of medicinal plants. BMC Complement Altern Med  2012; 12(1): 3.
 [http://dx.doi.org/10.1186/1472-6882-12-3] [PMID: 22244370]

[84]
Mondal S, Mirdha BR, Mahapatra SC. The science behind sacredness of Tulsi (Ocimum sanctum Linn.). Indian J Physiol Pharmacol  2009; 53(4): 291-306.
 [PMID: 20509321]

[85]
Kumar DV, Geethanjali B, Avinash KO, Kumar JR, Basalingappa KM. Tinospora cordifolia: The antimicrobial property of the leaves of amruthaballi. J BacteriolMycol Open Access  2017; 5(5): 363-71.

[86]
Dhama K, Sachan S, Khandia R, et al. Medicinal and beneficial health applications of Tinospora cordifolia (Guduchi): A miraculous herb countering various diseases/disorders and its immunomodulatory effects. Recent Pat Endocr Metab Immune Drug Discov  2017; 10(2): 96-111.
 [http://dx.doi.org/10.2174/1872214811666170301105101] [PMID: 28260522]

[87]
Ghosh S, Saha S. Tinospora cordifolia: One plant, many roles. Anc Sci Life  2012; 31(4): 151-9.
 [http://dx.doi.org/10.4103/0257-7941.107344] [PMID: 23661861]

[88]
Rana V, Thakur K, Sood R, Sharma V, Sharma TR. Genetic diversity analysis of Tinospora cordifolia germplasm collected from northwestern Himalayan region of India. J Genet  2012; 91(1): 99-103.
 [http://dx.doi.org/10.1007/s12041-012-0137-7] [PMID: 22546832]

[89]
Parthipan M, Aravindhan V, Rajendran A. Medico-botanical study of Yercaud hills in the eastern Ghats of Tamil Nadu, India. Anc Sci Life  2011; 30(4): 104-9.
 [PMID: 22557438]

[90]
Rastogi S, Pandey DN, Singh RH. COVID-19 pandemic: A pragmatic plan for ayurveda intervention. J Ayurveda Integr Med  2022; 13(1): 100312.
 [http://dx.doi.org/10.1016/j.jaim.2020.04.002] [PMID: 32382220]

[91]
Sharma U, Bala M, Kumar N, Singh B, Munshi RK, Bhalerao S. Immunomodulatory active compounds from Tinospora cordifolia. J Ethnopharmacol  2012; 141(3): 918-26.
 [http://dx.doi.org/10.1016/j.jep.2012.03.027] [PMID: 22472109]

[92]
Peterson CT, Denniston K, Chopra D. Therapeutic uses of triphala in ayurvedic medicine. J Altern Complement Med  2017; 23(8): 607-14.
 [http://dx.doi.org/10.1089/acm.2017.0083] [PMID: 28696777]

[93]
Mukherjee PK, Rai S, Bhattachar S. Clinical study of ‘TRIPHALA’–A well knownphytomedicine from India. Iran J PharmacolTher  2005; 5: 51-4.

[94]
Shanbhag V. Triphala in prevention of dental caries and as an antimicrobial in oral cavity-a review. Infect Disord Drug Targets  2015; 15(2): 89-97.
 [http://dx.doi.org/10.2174/1871526515666150513105009]

[95]
Belapurkar P, Goyal P, Tiwari-Barua P. Immunomodulatory effects of triphala and its individual constituents: A review. Indian J Pharm Sci  2014; 76(6): 467-75.
 [PMID: 25593379]

[96]
Kulkarni KV, Ghurghure SM. Indian gooseberry (Emblica officinalis): Complete pharmacognosy review. Int J Chem Stud  2018; 2(2): 5-11.

[97]
Khan KH. Roles of Emblica officinalis in medicine-A review. Bot Res Int  2009; 2(4): 218-28.

[98]
Srivasuki KP. Nutritional and health care benefits of Amla. J Pharmacogn  2012; 3(2): 141-51.

[99]
Milind P, Deepa K. Clove: A champion spice. Int J Res Ayurveda Pharm  2011; 2(1): 47-54.

[100]
Gopalakrishnan N, Narayanan CS, Mathew AG. Chemical composition of Indian clove bud, stem and leaf oils. Indian Perfumers  1988; 32: 229-35.

[101]
Narayanan CR, Natu AA. Triterpene acids of indian clove buds. Phytochemistry  1974; 13(9): 1999-2000.
 [http://dx.doi.org/10.1016/0031-9422(74)85139-3]

[102]
Rao PV, Gan SH. Cinnamon: A multifaceted medicinal plant. Evid Based Complement Alternat Med  2014; 2014: 1-12.
 [http://dx.doi.org/10.1155/2014/642942] [PMID: 24817901]

[103]
Vangalapati M, Satya NS, Prakash DS, Avanigadda S. A review on pharmacological activities and clinical effects of cinnamon species. Res J Pharm Biol Chem Sci  2012; 3(1): 653-63.

[104]
Sangal A. Role of cinnamon as beneficial antidiabetic food adjunct: A review. Adv Appl Sci Res  2011; 2(4): 440-50.

[105]
Lombard K, Peffley E, Geoffriau E, Thompson L, Herring A. Quercetin in onion (Allium cepa L.) after heat-treatment simulating home preparation. J Food Compos Anal  2005; 18(6): 571-81.
 [http://dx.doi.org/10.1016/j.jfca.2004.03.027]

[106]
Takooree H, Aumeeruddy MZ, Rengasamy KR, et al. A systematic review on black pepper (Piper nigrum L.): From folk uses to pharmacological applications Crit Rev Food Sci Nutr  2019; 59(sup1): S210-243.

[107]
Shang A, Cao SY, Xu XY, et al. Bioactive compounds and biological functions of garlic (Allium sativum L.). Foods  2019; 8(7): 246.
 [http://dx.doi.org/10.3390/foods8070246] [PMID: 31284512]

[108]
Wang B, Kovalchuk A, Li D, Ilnytskyy Y, Kovalchuk I, Kovalchuk O. In search of preventative strategies: Novel anti-inflammatory high-CBD cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues. Preprints 2020.
 [http://dx.doi.org/10.20944/preprints202004.0315.v1]

[109]
Shahid MA, Chowdhury MA, Kashem MA. Scope of natural plant extract to deactivate COVID-19. Research Square  2020; 2: 15.
 [http://dx.doi.org/10.21203/rs.3.rs-19240/v1]

[110]
Serseg T, Benarous K, Yousfi M. Hispidin and Lepidine E: Two natural compounds and folic acid as potential inhibitors of 2019-novel coronavirus Main Protease (2019-nCoVMpro), molecular docking and SAR study. Curr Computeraided Drug Des  2021; 17(3): 469-79.
 [http://dx.doi.org/10.2174/15734099MTA1lOTgfz] [PMID: 32321407]

[111]
Walter TM, Justinraj CS, Nandini VS. Effect of Nilavembukudineer in the Prevention and Management of COVID–19 by inhibiting ACE2 Receptor. Siddha Papers  2020; 15(2): 531.

[112]
Alabboud M, Javadmanesh A. In silico study of various antiviral drugs, vitamins, and natural substances as potential binding compounds with SARS-CoV-2 main protease. DYSONA-Life Science  2020; 1(2): 44-63.

[113]
Bouchentouf S, Missoum N. Identification of compounds from nigella sativa as new potential inhibitors of ChemRxiv 2019.
 [http://dx.doi.org/10.26434/chemrxiv.12055716.v1]

[114]
Giri S, Lal AF, Singh S. Battle against Coronavirus: Repurposing old friends (Food borne polyphenols) for new enemy (COVID-19). ChemRxiv 2016.

[115]
Rathinavel T, Palanisamy M, Palanisamy S, Subramanian A, Thangaswamy S. Phytochemical 6-gingerol-A promising drug of choice for COVID-19. Int J Adv Sci Eng  2020; 6(4): 1482-9.
 [http://dx.doi.org/10.29294/IJASE.6.4.2020.1482-1489]

[116]
Manuja A, Rathore N, Choudhary S, Kumar B. Phytochemical screening, cytotoxicity and anti-inflammatory activities of the leaf extracts from Lawsonia inermis of indian origin to explore their potential for medicinal uses. Med Chem  2021; 17(6): 576-86.
 [http://dx.doi.org/10.2174/1573406416666200221101953] [PMID: 32081108]

[117]
Maurya DK, Sharma D. Evaluation of traditional ayurvedic preparation for prevention and management of the novel coronavirus (SARS-CoV-2) using molecular docking approach. ChemRxiv 2020.
 [http://dx.doi.org/10.26434/chemrxiv.12110214.v1]

[118]
Mohammadi N, Shaghaghi N. Inhibitory effect of eight secondary metabolites from conventional medicinal plants on COVID_19 virus protease by molecular docking analysis. ChemRxiv 2020.
 [http://dx.doi.org/10.26434/chemrxiv.11987475.v1]

[119]
Thuy BTP, My TTA, Hai NTT, et al. Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega  2020; 5(14): 8312-20.
 [http://dx.doi.org/10.1021/acsomega.0c00772] [PMID: 32363255]

[120]
Borenstein R, Hanson BA, Markosyan RM, et al. Ginkgolic acid inhibits fusion of enveloped viruses. Sci Rep  2020; 10(1): 4746.
 [http://dx.doi.org/10.1038/s41598-020-61700-0] [PMID: 31913322]

[121]
Utomo RY, Ikawati M, Meiyanto E. Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection 2020 Preprints  2020; 2020030214.
 [http://dx.doi.org/10.20944/preprints202003.0214.v1]

[122]
Tahir ul Qamar M, Alqahtani SM, Alamri MA, Chen LL. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal  2020; 10(4): 313-9.
 [http://dx.doi.org/10.1016/j.jpha.2020.03.009] [PMID: 32296570]

[123]
Goswami D, Kumar M, Ghosh SK, Das A. Natural product compounds in alpiniaofficinarum and ginger are potent SARS-CoV-2 papain-like protease inhibitors. ChemRxiv 2020.
 [http://dx.doi.org/10.26434/chemrxiv.12071997.v1]

[124]
Srivastava AK, Kumar A, Misra N. On the inhibition of COVID-19 protease by Indian herbal plants: An in silico investigation. arXiv 2020.

[125]
Khan MF, Khan MA, Khan ZA, Ahamad T, Ansari WA. 2020.Identification of dietary molecules as therapeutic agents to combat COVID-19 using molecular docking studies. Research Square 2020.
 [http://dx.doi.org/10.21203/rs.3.rs-19560/v1]

[126]
Su W, Wang Y, Li P, et al. The potential application of the traditional Chinese herb Exocarpium Citri grandis in the prevention and treatment of COVID-19. Trad Med Res  2020; 5(3): 160-6.
 [http://dx.doi.org/10.53388/TMR20200406172]

[127]
Sharma AD, Kaur I. Molecular docking studies on Jensenone from eucalyptus essential oil as a potential inhibitor of COVID 19 corona virus infection. arXiv 2020.

[128]
Dhanasekaran S. Scope of phytotherapeutics in targeting ACE2 mediated Host-Viral Interface of SARS-CoV2 that causes COVID-19. ChemRxiv 2020.
 [http://dx.doi.org/10.26434/chemrxiv.12089730.v1]

[129]
Meneguzzo F, Ciriminna R, Zabini F, Pagliaro M. Hydrodynamic cavitation-based rapid expansion of hesperidin-rich products from waste citrus peel as a potential tool against COVID-19. Preprint  2020; 1-15.
 [http://dx.doi.org/10.20944/preprints202004.0152.v1]

[130]
Subhose V, Srinivas P, Narayana A. Basic principles of pharmaceutical science in Ayurvĕda. Bull Indian Inst Hist Med Hyderabad  2005; 35(2): 83-92.
 [PMID: 17333665]

[131]
Fortunatov MN. Experimental use of phytoncides for therapeutic and prophylactic purpose. VoprosyPediatriiiOkhranyMaterinstva  1952; 20(2): 55-8.

[132]
Kahlon JB, Kemp MC, Carpenter RH, McAnalley BH, McDaniel HR, Shannon WM. Inhibition of AIDS virus replication by acemannan in vitro. Mol Biother  1991; 3(3): 127-35.
 [PMID: 1768365]

[133]
Barnard DL, Huffman JH, Morris JLB, Wood SG, Hughes BG, Sidwell RW. Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral Res  1992; 17(1): 63-77.
 [http://dx.doi.org/10.1016/0166-3542(92)90091-I] [PMID: 1310583]

[134]
Semple SJ, Pyke SM, Reynolds GD, Flower RLP. In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus. Antiviral Res  2001; 49(3): 169-78.
 [http://dx.doi.org/10.1016/S0166-3542(01)00125-5] [PMID: 11428243]

[135]
Jakovljević D, Stanković M, Warchoł M, Skrzypek E. Basil (Ocimum L.) cell and organ culture for the secondary metabolites production: A review. Plant Cell Tissue Organ Cult  2022; 149(1-2): 61-79.
 [http://dx.doi.org/10.1007/s11240-022-02286-5]
Cite As
Current Nutrition & Food Science

Role of Indian Medicinal Plants for Immunity Booster Against SARS-CoV-2 Infection: An Updated Review

Abstract

Graphical Abstract
